FCHI8,141.92-0.19%
GDAXI24,083.53-0.19%
DJI49,167.79-0.13%
XLE57.090.56%
STOXX50E5,860.32-0.39%
XLF51.80-0.02%
FTSE10,321.09-0.56%
IXIC24,887.100.20%
RUT2,788.190.04%
GSPC7,173.910.12%
Temp26.7ยฐC
UV0
Feels29.2ยฐC
Humidity75%
Wind15.8 km/h
Air QualityAQI 1
Cloud Cover36%
Rain81%
Sunrise05:59 AM
Sunset06:47 PM
Time12:25 AM
8-KSEC Filing

Molina Healthcare Reaffirms 2026 Guidance After Mixed Q1 Results

8-K filed on April 22, 2026

April 22, 2026 at 12:00 AM

๐Ÿงพ What This Document Is

This is a first-quarter 2026 earnings report (an 8-K filing) from Molina Healthcare. Think of it as the company's "report card" for the first three months of the year. Its main job is to tell investors how much money they made, how much they spent, and what they expect for the rest of 2026.

๐Ÿ‘‰ Key takeaway: Molina is sharing its latest financial results and, importantly, is reaffirming its full-year financial targets, which is a sign of management's confidence.

๐Ÿข What The Company Does

๐Ÿ‘‰ In simple terms, Molina Healthcare is a major health insurance company that focuses on government-funded healthcare programs. They provide health coverage primarily through Medicaid (for low-income individuals) and Medicare (for seniors), and also sell plans on the Affordable Care Act (ACA) Marketplaces. They are a Fortune 500 company.

๐Ÿ’ฐ Financial Highlights: The Q1 Scorecard

Hereโ€™s a snapshot of how the first quarter (Jan-Mar 2026) went. The numbers show a mixed picture compared to last year.

Revenue:

  • Premium Revenue: $10.17 billion (down 4% from $10.63 billion in Q1 2025).
  • Total Revenue: $10.80 billion (down from $11.15 billion).

Profitability (The Two Sets of Books): Companies often report "GAAP" (the standard rules) and "Adjusted" numbers (which exclude one-time items) to show underlying performance.

  • GAAP Results (Standard Rules):

    • Net Income: $14 million, a huge drop from $298 million.
    • Earnings Per Share (EPS): $0.27, down from $5.45. ๐Ÿ‘‰ This big drop is mainly due to a one-time charge.
  • Adjusted Results (Underlying Performance):

    • Adjusted Net Income: $120 million (down from $333 million).
    • Adjusted EPS: $2.35 (down from $6.08). ๐Ÿ‘‰ This shows the core business is still profitable, though less so than last year.

โš–๏ธ The Cost of Care: Medical Care Ratio (MCR)

This is a crucial metric for health insurers. The MCR tells you what percentage of premium revenue is spent on actual medical claims (like doctor visits and hospital stays). A lower number is generally better.

  • Overall MCR: 91.1% (up from 89.2% last year).
    • ๐Ÿ‘‰ This means for every $1.00 Molina collected in premiums, they spent about 91 cents on healthcare services. The increase suggests costs rose faster than revenue this quarter.
  • By Segment:
    • Medicaid: 92.0%
    • Medicare: 89.8%
    • Marketplace: 84.0% (This was negatively impacted by about 4.5% due to prior-year risk adjustments).

๐Ÿš€ Key Strategic Move: Exiting a Business Line

A major non-financial news in this report is Molina's planned exit from the Medicare Advantage-Part D product line for 2027.

  • Why it matters: This caused a $93 million one-time impairment charge in Q1 (hurting GAAP earnings). Itโ€™s a strategic decision to simplify their business and focus on core strengths. Management is taking a short-term financial hit to reshape the company for the future.

๐Ÿ“ฆ Financial Position & Cash Flow

  • Balance Sheet: Cash at the parent company was $213 million, slightly down from year-end.
  • "Days in Claims Payable": 44 days. This measures how long it takes Molina to pay its medical bills. It was lower than usual this quarter, mainly due to timing of payments at quarter-end.
  • Cash Flow: Operating cash flow was a strong $1.08 billion for the quarter, a big improvement from $190 million last year. ๐Ÿ‘‰ This is a very positive sign, indicating healthy cash generation from operations, mainly due to the timing of government payments.

๐Ÿ”ฎ What's Next: 2026 Guidance Reaffirmed

This is the most forward-looking part of the report.

  • Full Year 2026 Premium Revenue: Still expected to be ~$42 billion (a ~2% decline from 2025).
  • Full Year 2026 Adjusted EPS: Still expected to be at least $5.00 per share.
  • ๐Ÿ‘‰ Why this matters: By reaffirming guidance after the first quarter, management is telling investors, "Our first-quarter results are in line with our annual plan, and we still expect to hit our targets for the whole year." They plan to update this guidance after Q2.

๐Ÿ“… Key Dates & Contacts

  • Conference Call: Management will discuss results on April 23, 2026, at 8:00 a.m. ET. Call (877) 883-0383, confirmation #4352622.
  • Investor Day: Mark your calendar for May 8, 2026, for a deeper dive into the company's three-year outlook.
  • Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012
  • Media Contact: Caroline Zubieta, [email protected], 562-951-1588

๐Ÿง  The Analogy

Think of Molina Healthcare like a public transit system. The Premium Revenue is the total fare money collected from riders. The Medical Care Ratio (MCR) is the cost of fuel, drivers, and maintenance to run the busesโ€”this quarter, those costs took up 91 cents of every fare dollar collected. The GAAP earnings drop is like a one-time cost to decommission an old, inefficient bus route (the Medicare-Part D exit). The reaffirmed guidance is the transit authority assuring the public that, despite a bumpy quarter, the overall annual schedule and budget are still on track. The strong cash flow is a good sign that fare collection and operational timing are working smoothly.

๐Ÿงฉ Final Takeaway

Molina Healthcare had a profitable but challenging Q1, with higher medical costs and lower revenue leading to significantly lower earnings. However, the core adjusted profit remained solid, cash generation was excellent, and most importantly, management stands by its full-year financial forecast. The strategic exit from Medicare Part D is a notable reshaping move with a short-term cost. Investors will look for stabilization in medical costs and membership trends in the coming quarters.